Radioimmunoassay of human placental lactogen

A sensitive and specific radioimmunossay procedure (RIA) has been developed for the measurement of Human Placental Lactogen (HPL). Pure HPL has been labelled with¹²⁵I and a specific activity of 100 μCi/μgm of HPL has been attained. Dextran-coated charcoal has been employed to separate the bound from the free hormone in radioimmuno-assay. The sensitivity of this technique has been found to be 0.2 ng of HPL. Intraassay and inter assay variations have been found to be less than 10%. This procedure has been adopted to establish the normal range of HPL in pregnant women at different periods of gestation, and to evaluate risk pregnancies.     

A single reagent thyroxine radioimmunoassay

An homogenous radioimmunoassay of thyroxine using labelled antigen antibody complex as a single reagent is described. Variation of dose response curve slope with assay incubation time has been studied at two different antisera concentrations. The dissociation constant of the complex was found to be 3.5·10⁻⁴ s⁻¹. The assay involves only three pipettings and requires 45 minutes incubation at 37 °C and 10 μl of serum. Though the assay is essentially a nonequilibrium type, apparent increase in sample values, due to the drift of dose response curve for 45 minutes delay was less than 7.5%. Within and between assay variations were both less than 5% c. v. Assay has been validated by recovery experiments. Analysis of 40 serum samples by the proposed method and by an equilibrium assay gave similar values; r=0.957, Y=0.955X+0.478.     

Simultaneous determination of MHD and DMD in dog plasma by high-performance liquid chromatography with fluorescence detection and its application to pharmacokinetic studies

A rapid, reproducible high-performance liquid chromatographic (HPLC) method with fluorescence detection for the simultaneous determination of 3(or 8)-(1-methoxyethyl)-8(or 3)-(1-hydroxyethyl)-deuteroporphyrin IX (MHD) and 3,8-di-(1-methoxyethyl)-deuteroporphyrin IX (DMD) in dog plasma was described. Fluorescein was used as an internal standard. A simple extraction step with ethyl acetate was performed before chromatography on a Diamonsil C₁₈ column (5 μm, 4.6 mm×150 mm). The chromatography used 0.02 mol L⁻¹ sodium acetate/tetrahydrofuran (66:34 v/v). The analytical curve was linear over the concentration range 0.025– 2.5 μg mL⁻¹. For a 100 μL dog plasma sample, the limit of determination for both MHD and DMD was 0.025 μg mL⁻¹. The recoveries of MHD and DMD were more than 76% and 89%, respectively. The intra-assay (within-run) and interassay (between-run) coefficients of variation (precisions) for MHD and DMD were less than 15%. This method was found to be suitable for the analysis of biosamples and was successfully applied to pharmacokinetic studies of Deuxemether in dogs.     

Validated LC Method, with a Chiral Mobile Phase, for Separation of the Isomers of Fexofenadine Hydrochloride

A rapid, simple and sensitive high-performance liquid chromatographic method (HPLC) has been developed to assay atomoxetine HCl in capsules. The HPLC analysis used a reversed phase C18 (150 × 4.6 mm i.d. 5 μm particle size) analytical column and a mobile phase consisting of monobasic potassium dihydrogen orthophosphate and acetonitrile (95:5 v/v), with UV detection at 269 nm. The validation data showed that the assay is sensitive, specific and reproducible for determination of atomoxetine HCl in this dosage form. Calibration curves were linear from 1 to 10 μg mL⁻¹ (R ² > 0.997). The accuracy of the method ranged from 98.13 to 101.5%. Mean inter- and intra-assay relative standard deviations (RSD) were less than 1.0%. The proposed method provided an accurate and precise analysis of atomoxetine HCl in its pharmaceutical dosage form.     

Highly Sensitive and Selective Detection of Creatinine by Combined Use of MISPE and a Complementary MIP-Sensor

Guanidinoacetate methyltransferase deficiency is a recently discovered inborn defect of creatine biosynthesis which reduces serum creatinine concentrations to as low as 0.58 μg mL⁻¹ (or 0.00058 μg mL⁻¹ after 1,000-fold dilution). To measure ultra trace levels of creatinine in diluted samples, molecularly imprinted solid-phase extraction (MISPE) and molecularly imprinted polymer (MIP) sensor techniques have been found to be inadequate. A combination of these techniques (i.e. MISPE hyphenated with use of an MIP-sensor), reported in this paper, has been found to be highly suitable for direct assay of creatinine in highly diluted human blood serum without complicated pretreatment of the sample. The proposed technique has the potential to enhance the sensitivity of creatinine measurement from μg mL⁻¹ to ng mL⁻¹ in highly dilute aqueous samples in which the concentrations of interfering constituents are reduced to negligible levels. In this work the sensitivity to creatinine was found to be improved compared with that of the MIP-sensor method alone (limit of detection, LOD, 0.00149 μg mL⁻¹). After preconcentration by MISPE and use of the sensor the detection limit for creatinine was as low as 0.00003 μg mL⁻¹ (RSD = 0.94%, S/N = 3; 50-fold preconcentration factor) in aqueous samples.     

Simultaneous Determination of Olanzapine and Fluoxetine by HPLC

A rapid, specific reversed phase HPLC method has been developed for simultaneous determination of olanzapine and fluoxetine in their formulations. Chromatographic separation of these two pharmaceuticals was carried out on an Inertsil C₁₈ reversed phase column (150 mm × 4.6 mm, 5 μm) with a 40:30:30 (v/v/v) mixture of 9.5 mM sodium dihydrogen phosphate (pH adjusted to 6.8 ± 0.1 with triethylamine), acetonitrile and methanol as mobile phase. The flow rate 1.2 mL min⁻¹ and the analytes are monitored at 225 nm. Paroxetine was used as internal standard. The assay results were linear from 25 to 75 μg mL⁻¹ for olanzapine (r ² ≥ 0.995) and 100–300 μg mL⁻¹ for fluoxetine (r ² ≥ 0.995), showed intra- and inter-day precision less than 1.0%, and accuracy of 97.7–99.1% and 97.9–99.0%. LOQ was 0.005 and 0.001 μg mL⁻¹ for olanzapine and fluoxetine, respectively. Separation was complete in less than 10 min. Validation of the method showed it to be robust, precise, accurate and linear over the range of analysis.     

Simultaneous Determination of Baicalin, Baicalein, Wogonin, Oxysophocarpine, Oxymatrine and Matrine in the Chinese Herbal Preparation of Sanwu-Huangqin-Tang by Ion-Paired HPLC

A sensitive and reliable ion-paired high-performance liquid chromatographic method has been established for the simultaneous quantification of six major active ingredients, namely baicalin, baicalein, wogonin, oxysophocarpine, oxymatrine and matrine in the Chinese herbal preparation, Sanwu-Huangqin-Tang. HPLC analyses were performed on a Phenomenex luna C₁₈ column with mobile phase of methanol–acetonitrile–aqueous phosphoric acid at a flow rate of 0.9 mL min⁻¹. The complete separation was achieved within 35 min for the six target constituents. A good linear regression relationship between peak-areas and concentrations was obtained over the range of 12.10–242.0 μg*mL⁻¹ for baicalin, 5.05–101.0 μg*mL⁻¹ for baicalein, 0.95–19.0 μg*mL⁻¹ for wogonin, 2.75–55.0 μg*mL⁻¹ for oxysophocarpin, 2.75–55.0 μg*mL⁻¹ for oxymatrine and 4.90–98.0 μg*mL⁻¹ for matrine, respectively. The repeatability was evaluated by intra- and inter-day assays with relative standard deviation (RSD) being less than 5.1%. The recoveries, measured at three concentration levels, varied from 93.8 to 102.1%. The assay was successfully applied for determination of six bioactive compounds in Sanwu-Huangqin-Tang. The interaction of chemical constituents was observed when the herbs were used in compatibility. The results indicated that the developed assay method was rapid, accurate and could be readily utilized as a quality control method for Sanwu-Huangqin-Tang.     

Rapid high-performance liquid chromatography determination of lopinavir, a novel HIV-1 protease inhibitor, in human plasma

Summary Lopinavir is a new specific and potent HIV-1 protease inhibitor. A rapid high-performance liquid chromatographic method using UV detection, has been developed and validated for the analysis of lopinavir in plasma. This involved a single liquid-solid extraction on an OASIS^? HLB column in the presence of an internal standard. Separation was achieved on a Xterra^?, C₈ (150×3.9 mm I.D.) column with a mobile phase consisting of acetonitrile and water (41∶59, v/v). The detection wavelength was 210 nm. The assay was linear from 0.187 to 10.0 μg.mL⁻¹ and the limit of quantification was 0.187 μg.mL⁻¹. Mean recovery was ranged from 90.7% to 97.8% for lopinavir and 97.1% for the internal standard. Day to day precision and accuracy were less than 9.6% and 7.3% respectively. This rapid and simple method can readily be used for drug monitoring of lopinavir, in HIV-1 infected patients.     

Gas chromatographic-mass spectrometric assay for 2-methoxyethanol and 2-methoxyacetic acid in human plasma and its application to pharmacokinetic studies

Summary A new assay has been developed for simultaneous measurement of 2-methoxyethanol (ME) and its major toxic metabolite, 2-methoxyacetic acid (MAA) in human blood by gas chromatography-mass spectrometry. Over the concentration range 0.3 to 200 μgml⁻¹, ME and MAA could be determined with a pooled coefficient of variation (eleven concentrations, six replicate samples) of 6.5% and 8.7%, respectively. The limits of quantification of ME and MAA were 0.19 and 0.05μg mL⁻¹, respectively. The respective mean (SD) recoveries of ME and MAA were 101.3 (2.6)% and 98.2 (4.9)% (n=3). A study of the effects of human contact with ME liquid showed that this new method is a specific, sensitive, simple, and reliable method both for the pharmacokinetic studies and for the biological monitoring of occupational exposure to ME.     

Multiresidue procedures for determination of triazine and organophosphorus pesticides in water by use of large-volume PTV injection in gas chromatography

Summary Two procedures, based on large-volume injection with a programmed-temperature vaporizer (PTV), have been developed for the determination of several triazine and organophosphorus pesticides. The use of PTV for injection in gas chromatography (GC) has enabled the introduction of up to 200 μL sample extract into the GC, thus increasing the sensitivity of the method. PTV injection has been combined off-line with two different microextraction procedures—liquid-liquid partition and solid-phase extraction. A simple and rapid off-line liquid-liquid microextraction procedure (5 mL water/1 mL methyltert-butyl ether) was applied to surface water samples spiked at levels between 0.01 and 5μg L⁻¹. Recoveries of the overall procedure were >80% and the precision was better than 15%. Detection limits were <30 ngL⁻¹ from 200-μL injections in GC-NPD analysis of triazines and GC-FPD analysis of organophosphorus pesticides. Off-line automated solid-phase extraction with C₁₈ cartridges has been applied to water samples (50 mL) spiked at 0.01, 0.1 and 1 μg L⁻¹. The overall procedure was satisfactory (recoveries >80% and coefficients of variation <12%) and the limits of detection ranged from 1 to 9 ng L⁻¹. Finally, several surface water samples were anlysed, and triazine herbicides were detected at concentrations of approx. 0.1–0.2 μg L⁻¹. The results were similar to those obtained by conventional solvent extraction then GC-MSD after splitless injection of 2 μL.     

A novel competitive fluorescence immunoassay for the determination of dibutyl phthalate

A novel, sensitive, and specific competitive fluorescence immunoassay has been developed for the quantitative determination of dibutyl phthalate (DBP) using an antibody-coated plate format. Hapten was synthesized in order to produce polyclonal antibodies against dibutyl phthalate. Polyclonal antisera to dibutyl phthalate were generated in rabbits and used to construct the fluorescence immunoassay for measurement of dibutylphthalate. The assay had a detection limit of about 0.02 μg L⁻¹, a dynamic range of approximately 0.1–300 μg L⁻¹. Other similar phthalate compounds do not interfere significantly in the analysis using this immunoassay technique, and the cross-reactivity rates were less than 10%. The study demonstrated that the developed antiserum and fluorescence immunoassay procedure can be used to detect dibutyl phthalate in environmental samples such as tap water, river water, drinking water, and leachate from plastic drinking water bottles.     

Trace analysis and occurrence of anhydroerythromycin and tylosin in influent and effluent wastewater by liquid chromatography combined with electrospray tandem mass spectrometry

Two wastewater treatment plants (WWTPs) of northern Colorado were monitored for anhydroerythromycin and tylosin. An analytical method has been developed and validated for the trace determination and confirmation of these compounds in the raw influent and final effluent water matrices. This method was used to evaluate the occurrence and fate of these compounds in WWTPs. The method uses solid-phase extraction and liquid chromatography–tandem mass spectrometry with positive electrospray ionization. Detection and quantification was performed using selected reaction monitoring, and a method detection limit of between 0.01 and 0.06 μg/L was obtained. Unequivocal confirmation analysis of analyte identity according to the criteria (based on the use of identification points) of the 2002/657/EC European Commission Decision was possible with satisfactory results. Average recoveries for the two compounds ranged from 89.2±9.7% for raw influent to 93.7±6.9% for effluent wastewaters. The within-run precision of the assay was found to be always less than 14.1% for the two analytes. The overall precision was always less than 13.7%. The relative uncertainty of the present assay was also evaluated and the combined relative uncertainty ranged from 6.4 to 15.5% over three days of the validation study. These compounds were partially removed in the WWTPs with a removal efficiency of >50%. The measured concentrations in raw influents and effluents ranged from 0.09–0.35 and 0.04–0.12 μg/L for anhydroerythromycin to 0.06–0.18 and ND–0.06 μg/L for tylosin, respectively. The results indicate that WWTP effluents are relevant point sources for residues of these compounds in the aquatic environment. These occurrence results were compared with those in WWTP wastewaters of other countries.     

Stereospecific analysis of flurbiprofen and its major metabolites in plasma and urine by chiral-phase liquid chromatography

Summary Direct chiral-phase HPLC methods have been developed for the determination of flurbiprofen and its major metabolites, namely 4′-hydroxyflurbiprofen and 3′-hydroxy-4′-methoxyflurbiprofen, in biological fluids using a derivatized amylose chiral stationary phase (CSP; Chiral-pak AD). Quantification of all three analytes, both free and conjugated, in urine was carried out following liquid-liquid extraction using tandem ultraviolet (UV) and fluorescence detection. Determination of flurbiprofen and the 4′-hydroxy-metabolite in plasma utilized the same CSP but required modification in the mobile phase composition and sole use of fluorescence detection. The urine assay was linear (r>0.998) between 0.05–10 μg mL⁻¹, 0.1–20 μg mL⁻¹ and 0.01–2 μg mL⁻¹ for the enantiomers of flurbiprofen, 4′-hydroxyflurbiprofen and 3′-hydroxy-4′-methoxyflurbiprofen respectively. The plasma assay was linear (r>0.997) between 0.1–6 μg mL⁻¹ and 0.01–0.6 μg mL⁻¹ for the enantiomers of flurbiprofen and 4′-hydroxyflurbiprofen respectively. Both assays, typically yielded within- and between-day imprecision and accuracy values less than 10% for the enantiomers of the different analytes. Initial volunteer studies suggest that the disposition of flurbiprofen displays modest enantioselectivity in humans.     

Micellar electrokinetic chromatography assay for the simultaneous quantification of urinary transferrin and albumin

A micellar electrokinetic chromatography (MEKC) method for simultaneous determination of urinary transferrin and albumin has been developed. The performance of the assay was evaluated. Under the optimum conditions, the linearity of transferrin and albumin is in the range of 10~1000 mg L^?1. The detection limits are 1.3 mg L^?1 for transferrin and 1.1 mg L^?1 for albumin, with relative standard deviations of less than 5.4%. The within-run and between-run coefficients of variation were <5.5% for transferrin and <8.2% for albumin, respectively. The recoveries of transferrin and albumin are 97.7~106.1%. The performance of the MEKC assay was compared with radioimmunoassay, and correlated well with this.     

Liquid-chromatographic determination of sulfadimidine in milk and eggs

A method for the determination/identification of residual sulfadimidine (SDD) in milk and eggs by high-performance liquid chromatography (HPLC) with a photo-diode array detector was developed. The sample preparation was performed by shaking with a mixture of 20% (w/v) trichloroacetic acid-methanol (4:1, v/v) followed by ultra-filtration using Molcut II^?. A LiChrospher^? 100 RP-8 (e) column and a mobile phase of 4% (v/v) acetic acid solution-acetonitrile (6:4, v/v) were used. The average recoveries from spiked SDD samples were 80.8–88.0% with coefficients of variation of 2.8–5.5%. The limits of detection in milk and eggs were 0.01 μg/mL and 0.01 μg/g, respectively. The total time required for the analysis of one sample was less than 20 min. Received: 7 October 1998 / Revised: 29 December 1998 / Accepted: 30 December 1998     

Utilization of cyclotron produced fast neutrons in the activation analysis for oxygen

The possible application of cyclotron-produced fast neutrons to activation analysis for oxygen based on the¹⁶O(n, p)¹⁶N reaction has been investigated. Neutrons were produced by bombarding a thick beryllium target with 22 to 45 MeV deuterons. It was found that the sensitivity increases rapidly with the energy of the deuterons. Using 45 MeV deuterons and a 10 μA beam current a sensitivity of about 20 counts per 1 μg oxigen could be achieved, enabling the determination of less than 1 μg oxigen. In a direct comparison it was experimentally established that the sensitivity for cyclotron-produced neutrons assuming a deuteron beam of about 10 μA, is up to two orders of magnitude higher than that achievable for 14 MeV neutrons with a flux of about 10¹⁰ n/s. The interference of fluorine is at about the same level for both the cyclotron-produced and 14 MeV neutrons. Using cyclotron-produced fast neutrons in the investigated energy range, sodium and magnesium can also interfere, but only to a very much lower extent.     

Separation and quantitation of oxprenolol in urine and pharmaceutical formulations by HPLC using a Chiralpak IC and UV detection

Abstract  

A stereoselective HPLC method has been developed for the simultaneous determination of oxprenolol enantiomers in urine and pharmaceutical products. Enantiomeric resolution of oxprenolol was achieved on cellulose tris(3,5-dichlorophenylcarbamate) immobilized onto a 5 μm spherical porous silica chiral stationary phase (CSP) known as Chiralpak IC with UV detection at 273 nm. The mobile phase consisted of n-hexane:isopropanol:triethylamine 70:30:0.1 (v/v/v) at a flow rate of 1.0 cm³/min. The method was validated for its linearity, accuracy, precision, and robustness. The calibration curves were linear over the range of 0.5–75 μg/cm³, with a detection limit of 0.1 μg/cm³ for each enantiomer. An average recovery of 99.0% and a mean relative standard deviation of 2.6% at 40.0 μg/cm³ for S-(−)- and R-(+)-enantiomers were obtained. The overall recoveries of oxprenolol enantiomers from pharmaceutical formulations were in the range 97.5–99.0%, with RSDs ranging from 0.6 to 0.8%. The mean extraction efficiency of oxprenolol from urine was in the range of 86.0–93.0% at 0.5–5 μg/cm³ for each enantiomer. The assay method proved to be suitable as a chiral quality control for oxprenolol formulations using HPLC and for therapeutic drug monitoring.     

Development of a dipstick immunoassay for quantitative determination of 2,4-dichlorophenoxyacetic acid in water, fruit and urine samples

A sensitive dipstick assay for 2,4-dichlorophenoxyacetic acid (2,4-D) detection was developed. The assay was based on the competitive reaction of 2,4-D and enzyme tracer with monoclonal antibodies immobilised on an Ultrabind^? membrane. The binding of enzyme tracer on the test strip was determined by a simple, portable reflectometer as remission at 657 nm. Using this technique, 2,4-D could be detected in a concentration range of 0.5 μg/L to 100 μg/L. The center point of the 2,4-D test was found at a concentration of 6 μg/L. Cross-reactivity with 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) as determined by this dipstick assay was 2.5% and 3% by standard ELISA technique using microtiter plates. The assay was applied in the detection of 2,4-D in real water samples, and sensitivity was comparable to spiked water samples. If combined with an effective extraction procedure that results in recovery rates of 90%, the dipstick assay can be used to monitor human exposure to 2,4-D from contamination in water, from oranges and in testing urine samples. Received: 2 September 1998 / Revised: 29 January 1999 / Accepted: 31 January 1999     

Fluorescent microscopic determination of gatifloxacin in milk,injection, human urine,and rabbit serum samples by self-ordered ring technique on glass slides support

A simple and sensitive self-ordered ring (SOR) technique, which was based on the capillary effect of solvent on a hydrophobic glass slide, was successfully applied to the determination of gatifloxacin in milk, injection, human urine and rabbit serum samples. In a medium of pH 3.20 (HAc-NaAc) with the aid of poly(vinyl alcohol)-124 (PVA-124), when 0.50 μL aluminum-sensitized gatifloxacin was dropped on glass slide with dimethyl dichlorosilane (DMCS) pretreated, a typical fluorescent SOR with diameter (2R) of the ring less than ca. 1.77 mm and the belt width (2δ) less than 29.3 μm can be obtained. The solute on the ring belt had strong fluorescence. Data of the imaged SOR showed that the gatifloxacin molecule across the SOR belt section follows a Gaussian distribution. The assay showed that when the droplet volume is 0.1 μL, the SOR method could be used to determine gatifloxacin in the range of 5.61 × 10⁻¹⁴ ∼ 1.50 × 10⁻¹² mol/ring (5.61 × 10⁻⁸∼1.50 × 10⁻⁵ M) and the limit of determination (LOD) reached 5.61 × 10⁻¹⁵ mol/ring (5.61 × 10⁻⁸ M) with three-fold signal-to-noise ratio (S/N = 3).     

Folate analysis in foods by UPLC-MS/MS: development and validation of a novel, high throughput quantitative assay; folate levels determined in Australian fortified breads

An ultra-performance liquid chromatography-tandem mass spectrometry method was developed, optimised and validated for the quantification of synthetic folic acid (FA), also called pteroyl-l-glutamic acid or vitamin B9 and naturally occurring 5-methyltetrahydrofolate (5-MTHF) found in folate-fortified breads. Optimised sample preparation prior to analysis involved addition of ¹³C₅ labelled internal standards, treatments with α-amylase and rat serum, solid-phase extraction using aromatic-selective cartridges and ultra-filtration. Analytes were separated on a Waters ACQUITY HSS T3 column during a 6-min run and analysed by positive ion electrospray selected reaction monitoring MS/MS. Standard calibration curves for the two analytes were linear over the range of 0.018–14 μg FA/g of fresh bread (r ² = 0.997) and 9.3–900 ng 5-MTHF/g of fresh bread (r ² = 0.999). The absolute recoveries were 90% and 76% for FA and 5-MTHF, respectively. Intra-day coefficients of variation were 3% for FA and 18% for 5-MTHF. The limit of detection was 9.0 ng/g for FA and 4.3 ng/g for 5-MTHF, determined using pre-extracted tapioca starch as the blank matrix. The assay is rugged, fast, accurate and sensitive, applicable to a variety of food matrices and is capable of the detection and quantification of the naturally occurring low levels of 5-MTHF in wheat breads. The findings of this study revealed that the FA range in Australian fortified breads was 79–110 μg/100 g of fresh bread and suggest that the flour may not have the mandated FA fortification level (200–300 μg/100 g of flour), though this cannot be determined conclusively from experimental bread data alone, as variable baking losses have been documented by other authors.